MEDFAR, a leading Canadian EMR provider, has acquired New York-based COMTRON, including Medgen EHR, LABGEN LIS, and RCM software, expanding its footprint in the U.S. primary care market. This integration enhances MEDFAR's MYLE Integrated Care Platform, streamlining primary care workflows and benefiting patients, labs, and providers. The acquisition aligns with MEDFAR's goal to support 5 million care providers in delivering high-quality care to 500 million patients globally.

MEDFAR Unveils New Brand Identity Reflecting Its Growth and Ambitious Healthcare GoalsMONTREAL, Aug. 8, 2024 /PRNewswire/ - MEDFAR, developer of the Integrated Care Platform MYLE and leading Canadian EMR provider, has successfully completed the integration of New York-based COMTRON, establishing a strategic foothold in the U.S. primary care market. With the acquisition of Medgen electronic health records (EHR), LABGEN LIS for medical laboratories, and revenue cycle management (RCM) software & services, MEDFAR now offers a comprehensive suite of tools for primary healthcare professionals across the United States.Since pioneering the first web-based EMR in Quebec, MEDFAR's innovative approach has fueled steady and exponential growth. Its core product, the MYLE Integrated Care Platform, has become the #1 solution used by primary care teams, and is the fastest growing EMR in Canada."This latest integration fast tracks MEDFAR's mission of driving excellence and efficiency in healthcare globally," said Elias Farah, CEO and co-founder of MEDFAR. "Lab Information System (LIS) and advanced RCM software and service capabilities add a crucial dimension to our MYLE Integrated Care Platform

MEDFAR announced as one of Deloitte's Technology Fast 50™ in Canada and Technology Fast 500™ program winners in North America for 2023.